Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07225751 · ClinicalTrials.gov registry record · NA
A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.
A NA study of Hindfoot Arthrodesis and Ankle Arthrodesis or Arthroplasty, sponsored by Kuros Biosurgery.
- Recruiting
- Registry status
- NA
- Development phase
- 126
- Enrollment target
- 4
- Study locations
NCT07225751: Recruiting NA study of Hindfoot Arthrodesis and Ankle Arthrodesis or Arthroplasty, sponsored by Kuros Biosurgery.
NCT07225751 is a NA study of Hindfoot Arthrodesis and Ankle Arthrodesis or Arthroplasty that is actively recruiting participants, run by Kuros Biosurgery. The registered enrollment target is 126 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07225751, a NA study of Hindfoot Arthrodesis and Ankle Arthrodesis or Arthroplasty, is actively recruiting participants, sponsored by Kuros Biosurgery.
- RECRUITING
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a phase IV post-marketing study for MagnetOs Putty and MagnetOs Easypack Putty. MagnetOs is a synthetic bone graft extender product that is routinely used by surgeon as treatment for hindfoot and ankle disorders. In this study, MagnetOs Putty and MagnetOs Easypack Putty will be use according to the latest Instructions For Use, standalone in the foot and ankle.
Primary Outcome
The primary endpoint is the incidence of fusion at each side by CT analysis as assessed by the independent radiological expert at 24 weeks post-op
Conditions Studied
Interventions
- DEVICE MagnetOs
- OTHER Autograft
Study Locations (4)
Colorado
- Steadman Philippon Research Institute - Vail
Georgia
- Hughston Foundation Inc - Columbus
Pennsylvania
- Reconstructive Orthopaedic Associates II dba Rothman Orthopaedic Institute - Philadelphia
Tennessee
- Erlanger Orthopaedics - Chattanooga
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2025-11-25 |
| Est. Completion | 2028-12 |
| Phase | NA |
What NCT07225751 shows while recruiting
NCT07225751 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 6 conditions, with Hindfoot Arthrodesis appearing as the primary indexed condition, and to 2 interventions - of which MagnetOs is the first listed.
NCT07225751 reports a single indexed study location in Colorado, Georgia, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07225751 about?
NCT07225751 is a clinical study titled "A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.". This is a phase IV post-marketing study for MagnetOs Putty and MagnetOs Easypack Putty. MagnetOs is a synthetic bone graft extender product that is routinely used by surgeon as treatment for hindfoot and ankle disorders. In this study, MagnetOs Putty and MagnetOs Easypack Putty will be use accordin...
What is the current status of trial NCT07225751?
This trial is currently recruiting. It is a NA study. The enrollment target is 126 participants. The study started on 2025-11-25. Estimated completion is 2028-12.
What conditions does trial NCT07225751 study?
This clinical trial studies the following conditions: Hindfoot Arthrodesis, Ankle Arthrodesis or Arthroplasty, Hindfoot Fusion, Ankle Deformity, Ankle Disease.
What interventions are being tested in trial NCT07225751?
The interventions under investigation include: MagnetOs (DEVICE), Autograft (OTHER).
Who is sponsoring clinical trial NCT07225751?
This trial is sponsored by Kuros Biosurgery, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07225751 being conducted?
This trial has 4 study locations across Colorado, Georgia, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hindfoot Arthrodesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07225751's enrollment target sits among peer trials
126 749th of 2000 higher than 1,248 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI